| AKT | AKT serine/threonine kinase 1 |
| AUC | area under the curve |
| ALK | anaplastic lymphoma kinase |
| CT | computed tomography |
| CYP | cytochrome P450 |
| EMA | European Medicines Agency |
| ERK | extracellular-signal regulated kinase |
| FAK | focal adhesion kinase |
| FDA | U.S. Food and Drug administration |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase |
| IGF | insulin-like growth factor |
| IGF1R | insulin-like growth factor 1 receptor |
| IGFBP | insulin-like growth factor-binding protein |
| INSR | insulin receptor |
| LDH | lactate dehydrogenase |
| NSCLC | non small cell lung cancer |
| OS | osteosarcoma |
| PPP | picropodophyllin |
| Ph+ ALL | philadelphia chromosome-positive acute lymphoblastic leukemia |
| Ph+ CML | philadelphia chromosome–positive chronic myeloid leukemia |
| RECIST | Response evaluation criteria in solid tumors |
| ROS1 | ROS proto-oncogene 1 |
| Src | Proto-oncogene tyrosine-protein kinase Src |
| TKI | tyrosine kinase inhibitor |
| UPLC-MS/MS | ultra performance liquid chromatography—tandem mass spectrometer |